Market sentiment signals for Xenon Pharmaceuticals (XENE): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
19 analysts
Options Flow (P/C)
0.24
More calls — Bullish
Avg Consensus PT
$62
+75.6%
Highest Price Target
$90
+155.4%
Lowest Price Target
$46
+30.5%
Short Interest
6.3%
Declining — Bullish
Insider Activity (30d)
Net Buyer
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | Guggenheim | Delma Caiati— | +107.1% | $73 | Assumes | Buy |
| Sep 18, 2026 | RBC Capital | Brian Abrahams— | +98.6% | $81 → $70 | Maintained | Outperform |
